Buy now

  

|

Buy now

References

References:

* The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView

# The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp and FreeStyle LibreLink may require registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app

^ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

  1. Finger pricks are required if your glucose readings do not match symptoms or expectations.
  2. Leelarathna, L. N Engl J Med. (2022): DOI: 10.1056/NEJMoa2205650
  3. Yaron, M. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.
  4. Evans M., Diabetes Ther. (2022): http://doi.org/10.1007/s13300-022-01253-9
  5. Bolinder, J. Lancet (2016): https://doi.org/10.1016/S0140-6736(16)31535-5.
  6. Haak, T. Diabetes Ther (2017): https://doi.org/10.1007/s13300-016-0223-6.
  7. Alva, S. J Diabetes Sci Technol (2020): https://doi.org/10.1177/1932296820958754.
  8. NOTE: statistically significant A1c reduction based on the confidence interval range
  9. Charleer S, et al. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Diabetes Care. 2020;43(2):389-397. https://doi.org/10.2337/dc19-1610
  10. Kao K., J Diabetes Sci. Technol. (2021): https://doi.org/10.1177/19322968211044141
  11. The reader can capture data from the sensor when it is within 1 cm to 4 cm of the sensor
  12. Sensor is water resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
  13. Wright E, et al. Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy. Diabetes Spectrum. 2021;34(2):184–189. https://doi.org/10.2337/ds20-0069
  14. Battelino T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019. https://doi.org/10.2337/dci19-0028
  15. Fokkert, M. BMJ Open Diab Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809
  16. Scott EM, Bilous RW, Kautzky-Willer A. Accuracy, user acceptability, and safety evaluation for the FreeStyle Libre flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther. 2018;20(3):180–188.
  17. Campbell FM, et al. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018 Nov;19(7):1294–1301. doi:10.1111/pedi.12735
  18. Scanning the sensor to obtain glucose values does not require lancets. To get a 24-hour glycaemic picture, users need to scan at least once every 8 hours
  19. Beck RW, et al. Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care. 2019;42(3):400–405. https://doi.org/10.2337/dc18-1444.
  20. Ajjan R, et al. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Adv Ther. 2019;36:579–596. https://doi.org/10.1007/s12325-019-0870-x
  21. Rao PV, Makkar BM, Viswanathan. RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India. International Journal of Diabetes in Developing Countries. 2018;38:260–279
  22. Joshi SR. Glycemic Variability and Ambulatory Glucose Profile in Indian Diabetics. JAPI. 2016
  23. Borgharkar SS, Das SS. Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study. BMJ Open Diab Res Care. 2019;7:e000654. doi:10.1136/bmjdrc-2019-000654
  24. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Diet, Eating, & Physical Activity. 2016. Accessed 25 Aug 2022. Available at: https://www.niddk.nih.gov/health-information/diabetes/overview/diet-eating-physical-activity
  25. The LibreView works with Windows 8.1 or Windows 10 Anniversary update and higher. The LibreLink works with an iPhone 8 or higher running iOS 15.5 or higher to utilize the NFC capability needed to scan the FreeStyle Libre sensor
  26. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycaemia or impending hypoglycaemia is reported by the system or when symptoms do not match the system readings.
  27. The FreeStyle LibreLink App and the FreeStyle Libre reader have similar but not identical features. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycaemia or impending hypoglycaemia is reported by the LibreLink App or when symptoms do not match the FreeStyle LibreLink App readings.
  28. The user must be connected to the internet in order for their glucose data to automatically upload to LibreView.
  29. CarlsonA.,Diabetes.(2021): https://doi.org/10.2337/db21-71-LB

The FreeStyle Libre continuous glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver at least 18 years old who is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings.

Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. Always read the label and use as directed.

For more information call Customer Service on 1800 2100 998

No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of AHPL, except to identify the product or services of the company. The product images are for illustrative purposes only.

Disclaimer
www.FreeStyleLibre.co.in is a product-specific website intended only for residents of India. If you are resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.

Abbott Logo

© 2023 Abbott. All rights reserved. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. ADC-82306 v2.0 11/23

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?